# Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

> **NCT06058650** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 70 (estimated)

## Conditions studied

- Breast Neoplasm

## Interventions

- **PROCEDURE:** Biopsy of Breast
- **OTHER:** Medical Device Usage and Evaluation
- **RADIATION:** Scintimammography
- **OTHER:** Technetium Tc-99m Sestamibi

## Key facts

- **NCT ID:** NCT06058650
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-26
- **Primary completion:** 2026-08-26
- **Final completion:** 2026-08-26
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058650, "Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06058650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*